Scientific Support

NaturalPQQ™

Scientific Support & Reference Citations References

 

  1. HAUGE JG GLUCOSE DEHYDROGENASE OF BACTERIUM ANITRATUM: AN ENZYME WITH A NOVEL PROSTHETIC GROUP. J Biol Chem. (1964)
  2. Anthony C Pyrroloquinoline quinone (PQQ) and quinoprotein enzymes. Antioxid Redox Signal. (2001)
  3. Kumazawa T1, et al Levels of pyrroloquinoline quinone in various foods. Biochem J. (1995)
  4. Noji N, et al Simple and sensitive method for pyrroloquinoline quinone (PQQ) analysis in various foods using liquid chromatography/electrospray-ionization tandem mass spectrometry. J Agric Food Chem. (2007)
  5. Mitchell AE, et al Characterization of pyrroloquinoline quinone amino acid derivatives by electrospray ionization mass spectrometry and detection in human milk. Anal Biochem. (1999)
  6. Mitchell AE, et al Characterization of Pyrroloquinoline Quinone Amino Acid Derivatives by Electrospray Ionization Mass Spectrometry and Detection in Human Milk. Anal Biochem. (1999)
  7. Steinberg F, et al Pyrroloquinoline quinone improves growth and reproductive performance in mice fed chemically defined diets. Exp Biol Med (Maywood). (2003)
  8. Ikemoto K, Sakamoto H, Nakano M Crystal structure and characterization of pyrroloquinoline quinone disodium trihydrate. Chem Cent J. (2012)
  9. Ishida T, et al Molecular and crystal structure of PQQ (methoxatin), a novel coenzyme of quinoproteins: extensive stacking character and metal ion interaction. J Am Chem Soc. (1989)
  10. Rucker R, Chowanadisai W, Nakano M Potential physiological importance of pyrroloquinoline quinone. Altern Med Rev. (2009)
  11. Kim J, et al Pyrroloquinoline quinone inhibits the fibrillation of amyloid proteins. Prion. (2010)
  12. Mukai K, Ouchi A, Nakano M Kinetic study of the quenching reaction of singlet oxygen by Pyrroloquinolinequinol (PQQH(2), a reduced form of Pyrroloquinolinequinone) in micellar solution. J Agric Food Chem. (2011)
  13. Yoshida W, et al Partial peptide of α-synuclein modified with small-molecule inhibitors specifically inhibits amyloid fibrillation of α-synuclein. Int J Mol Sci. (2013)
  14. Adachi O, et al Adduct formation of pyrroloquinoline quinone and amino acid. Biofactors. (1988)
  15. Zhang Y, Rosenberg PA The essential nutrient pyrroloquinoline quinone may act as a neuroprotectant by suppressing peroxynitrite formation. Eur J Neurosci. (2002)
  16. Kasahara T, Kato T Nutritional biochemistry: A new redox-cofactor vitamin for mammals. Nature. (2003)
  17. Felton LM, Anthony C Biochemistry: role of PQQ as a mammalian enzyme cofactor. Nature. (2005)
  18. Rucker R, et al Biochemistry: is pyrroloquinoline quinone a vitamin. Nature. (2005)
  19. Wang L, et al Cloning and characterization of a novel human homolog* of mouse U26, a putative PQQ-dependent AAS dehydrogenase. Mol Biol Rep. (2005)
  20. Bauerly KA, et al Pyrroloquinoline quinone nutritional status alters lysine metabolism and modulates mitochondrial DNA content in the mouse and rat. Biochim Biophys Acta. (2006)
  21. Stites TE, Mitchell AE, Rucker RB Physiological importance of quinoenzymes and the O-quinone family of cofactors. J Nutr. (2000)
  22. Goodwin PM, Anthony C The Biochemistry, Physiology and Genetics of PQQ and PQQ-containing Enzymes. Adv Microb Physiol. (1998)
  23. Puehringer S, Metlitzky M, Schwarzenbacher R The pyrroloquinoline quinone biosynthesis pathway revisited: a structural approach. BMC Biochem. (2008)
  24. Flückiger R, et al Characterization of the glycine-dependent redox-cycling activity in animal fluids and tissues using specific inhibitors and activators: evidence for presence of PQQ. Biochem Biophys Res Commun. (1993)
  25. Flückiger R, Paz MA, Gallop PM Redox-cycling detection of dialyzable pyrroloquinoline quinone and quinoproteins. Methods Enzymol. (1995)
  26. Stites T, et al Pyrroloquinoline quinone modulates mitochondrial quantity and function in mice. J Nutr. (2006)
  27. Bauerly K, et al Altering pyrroloquinoline quinone nutritional status modulates mitochondrial, lipid, and energy metabolism in rats. PLoS One. (2011)
  28. Harris CB, et al Dietary pyrroloquinoline quinone (PQQ) alters indicators of inflammation and mitochondrial-related metabolism in human subjects. J Nutr Biochem. (2013)
  29. Paz MA, et al The catalysis of redox cycling by pyrroloquinoline quinone (PQQ), PQQ derivatives, and isomers and the specificity of inhibitors. Anal Biochem. (1996)
  30. Paz MA, et al Specific detection of quinoproteins by redox-cycling staining. J Biol Chem. (1991)
  31. Salisbury SA, et al A novel coenzyme from bacterial primary alcohol dehydrogenase. Nature. (1979)
  32. Dooley DM, et al The generation of an organic free radical in substrate-reduced pig kidney diamine oxidase-cyanide. FEBS Lett. (1987)
  33. van der Meer RA, et al Primary structure of a pyrroloquinoline quinone (PQQ) containing peptide isolated from porcine kidney diamine oxidase. Biochem Biophys Res Commun. (1989)
  34. Groen BW, van der Meer RA, Duine JA Evidence for PQQ as cofactor in 3,4-dihydroxyphenylalanine (dopa) decarboxylase of pig kidney. FEBS Lett. (1988)
  35. van der Meer RA, Jongejan JA, Duine JA Dopamine beta-hydroxylase from bovine adrenal medulla contains covalently-bound pyrroloquinoline quinone. FEBS Lett. (1988)
  36. Robertson JG, et al Spectral studies of bovine dopamine beta-hydroxylase. Absence of covalently bound pyrroloquinoline quinone. J Biol Chem. (1989)
  37. Duine JA PQQ in plants (and animals). Trends Biochem Sci. (1991)
  38. Klinman JP, et al Status of the cofactor identity in copper oxidative enzymes. FEBS Lett. (1991)
  39. Kamata H, Hirata H Redox regulation of cellular signalling. Cell Signal. (1999)
  40. Ouchi A1, et al Kinetic study of the antioxidant activity of pyrroloquinolinequinol (PQQH(2), a reduced form of pyrroloquinolinequinone) in micellar solution. J Agric Food Chem. (2009)
  41. Kimura K, et al Pyrroloquinoline quinone stimulates epithelial cell proliferation by activating epidermal growth factor receptor through redox cycling. Free Radic Biol Med. (2012)
  42. Takada M, et al Pyrroloquinoline quinone, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves impaired glucose tolerance in diabetic KK-A(y) mice. Biochem Biophys Res Commun. (2012)
  43. Arnér ES, Holmgren A Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem. (2000)
  44. Xu J, Arnér ES Pyrroloquinoline quinone modulates the kinetic parameters of the mammalian selenoprotein thioredoxin reductase 1 and is an inhibitor of glutathione reductase. Biochem Pharmacol. (2012)
  45. Cenas N, et al Interactions of nitroaromatic compounds with the mammalian selenoprotein thioredoxin reductase and the relation to induction of apoptosis in human cancer cells. J Biol Chem. (2006)
  46. Brigelius-Flohé R, et al The yin and yang of nrf2-regulated selenoproteins in carcinogenesis. Int J Cell Biol. (2012)
  47. Locy ML, et al Thioredoxin reductase inhibition elicits nrf2-mediated responses in clara cells: implications for oxidant-induced lung injury. Antioxid Redox Signal. (2012)
  48. Suvorova ES, et al Cytoprotective Nrf2 pathway is induced in chronically txnrd 1-deficient hepatocytes. PLoS One. (2009)
  49. Tchaparian E, et al Identification of transcriptional networks responding to pyrroloquinoline quinone dietary supplementation and their influence on thioredoxin expression, and the JAK/STAT and MAPK pathways. Biochem J. (2010)
  50. Puigserver P Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-alpha. Int J Obes (Lond). (2005)
  51. Chowanadisai W, et al Pyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and increased PGC-1alpha expression. J Biol Chem. (2010)
  52. Steinberg FM, Gershwin ME, Rucker RB Dietary pyrroloquinoline quinone: growth and immune response in BALB/c mice. J Nutr. (1994)
  53. Wasserman K, et al Lactate, pyruvate, and lactate-to-pyruvate ratio during exercise and recovery. J Appl Physiol (1985). (1985)
  54. Guan M, et al Systemic perturbations of key metabolites in diabetic rats during the evolution of diabetes studied by urine metabonomics. PLoS One. (2013)
  55. Terán-García M, Ibarra I, Velázquez A Urinary organic acids in infant malnutrition. Pediatr Res. (1998)
  56. Kumazawa T, et al Activation of Ras signaling pathways by pyrroloquinoline quinone in NIH3T3 mouse fibroblasts. Int J Mol Med. (2007)
  57. Ishii T, et al Pro-oxidant action of pyrroloquinoline quinone: characterization of protein oxidative modifications. Biosci Biotechnol Biochem. (2010)
  58. Lee SR, et al Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J Biol Chem. (1998)
  59. Rhee SG, et al Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci STKE. (2000)
  60. Huyer G, et al Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J Biol Chem. (1997)
  61. Goldstein BJ Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity and related states of insulin resistance. Curr Drug Targets Immune Endocr Metabol Disord. (2001)
  62. Cantó C, Auwerx J Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)?. Pharmacol Rev. (2012)
  63. Boutant M, Cantó C SIRT1 metabolic actions: Integrating recent advances from mouse models. Mol Metab. (2013)
  64. Li X SIRT1 and energy metabolism. Acta Biochim Biophys Sin (Shanghai). (2013)
  65. Herranz D, et al Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer. Nat Commun. (2010)
  66. Banks AS, et al SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metab. (2008)
  67. Pfluger PT, et al Sirt1 protects against high-fat diet-induced metabolic damage. Proc Natl Acad Sci U S A. (2008)
  68. Kendrick AA, et al Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation. Biochem J. (2011)
  69. Brenmoehl J, Hoeflich A Dual control of mitochondrial biogenesis by sirtuin 1 and sirtuin 3. Mitochondrion. (2013)
  70. Smidt CR, et al Intestinal absorption and tissue distribution of {14C}pyrroloquinoline quinone in mice. Proc Soc Exp Biol Med. (1991)
  71. VanEngelen MR, et al Uranium exerts acute toxicity by binding to pyrroloquinoline quinone cofactor. Environ Sci Technol. (2011)
  72. Schürer G Is the calcium-ion catalysis of biological reoxidation of reduced PQQ purely electrostatic?. Chem Commun. (1998)
  73. Zheng YJ, Bruice TC Conformation of coenzyme pyrroloquinoline quinone and role of Ca2+ in the catalytic mechanism of quinoprotein methanol dehydrogenase. Proc Natl Acad Sci U S A. (1997)
  74. Aizenman E, Hartnett KA, Reynolds IJ Oxygen free radicals regulate NMDA receptor function via a redox modulatory site. Neuron. (1990)
  75. Aizenman E, Lipton SA, Loring RH Selective modulation of NMDA responses by reduction and oxidation. Neuron. (1989)
  76. Tang LH, Aizenman E The modulation of N-methyl-D-aspartate receptors by redox and alkylating reagents in rat cortical neurones in vitro. J Physiol. (1993)
  77. Aizenman E, et al Further evidence that pyrroloquinoline quinone interacts with the N-methyl-D-aspartate receptor redox site in rat cortical neurons in vitro. Neurosci Lett. (1994)
  78. Aizenman E, et al Interaction of the putative essential nutrient pyrroloquinoline quinone with the N-methyl-D-aspartate receptor redox modulatory site. J Neurosci. (1992)
  79. Scanlon JM, Aizenman E, Reynolds IJ Effects of pyrroloquinoline quinone on glutamate-induced production of reactive oxygen species in neurons. Eur J Pharmacol. (1997)
  80. Zhang Q, et al Pyrroloquinoline quinone rescues hippocampal neurons from glutamate-induced cell death through activation of Nrf2 and up-regulation of antioxidant genes. Genet Mol Res. (2012)
  81. Zhang Q, et al Pyrroloquinoline quinine protects rat brain cortex against acute glutamate-induced neurotoxicity. Neurochem Res. (2013)
  82. Zhang Q, et al The neuroprotective action of pyrroloquinoline quinone against glutamate-induced apoptosis in hippocampal neurons is mediated through the activation of PI3K/Akt pathway. Toxicol Appl Pharmacol. (2011)
  83. Panov A, et al Rotenone model of Parkinson disease: multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication. J Biol Chem. (2005)
  84. Sherer TB, et al Mechanism of toxicity in rotenone models of Parkinson’s disease. J Neurosci. (2003)
  85. Qin J, et al Pyrroloquinoline quinone-conferred neuroprotection in rotenone models of Parkinson’s disease. Toxicol Lett. (2015)
  86. Yamaguchi K, et al Stimulation of nerve growth factor production by pyrroloquinoline quinone and its derivatives in vitro and in vivo. Biosci Biotechnol Biochem. (1993)
  87. Urakami T, et al Synthesis of esters of coenzyme PQQ and IPQ, and stimulation of nerve growth factor production. Biofactors. (1995-1996)
  88. Yamaguchi K, et al Cyclooxygenase induction is essential for NGF synthesis enhancement by NGF inducers in L-M cells. Biosci Biotechnol Biochem. (1996)
  89. He B, Liu SQ, Li HH The roles of PI3K/Akt pathway in proliferation of Schwann cells promoted by pyrroloquinoline quinone. Zhonghua Zheng Xing Wai Ke Za Zhi. (2010)
  90. Hatanaka M, et al 15d-prostaglandin J2 enhancement of nerve growth factor-induced neurite outgrowth is blocked by the chemoattractant receptor- homologous molecule expressed on T-helper type 2 cells (CRTH2) antagonist CAY10471 in PC12 cells. J Pharmacol Sci. (2010)
  91. Bulló M, Peeraully MR, Trayhurn P Stimulation of NGF expression and secretion in 3T3-L1 adipocytes by prostaglandins PGD2, PGJ2, and Delta12-PGJ2. Am J Physiol Endocrinol Metab. (2005)
  92. Toyomoto M, et al Prostaglandins are powerful inducers of NGF and BDNF production in mouse astrocyte cultures. FEBS Lett. (2004)
  93. Satoh T, et al Prostaglandin J2 and its metabolites promote neurite outgrowth induced by nerve growth factor in PC12 cells. Biochem Biophys Res Commun. (1999)
  94. Murase K, et al Stimulation of nerve growth factor synthesis/secretion in mouse astroglial cells by coenzymes. Biochem Mol Biol Int. (1993)
  95. Liu S, et al Enhanced rat sciatic nerve regeneration through silicon tubes filled with pyrroloquinoline quinone. Microsurgery. (2005)
  96. Satake K, et al Nitric oxide via macrophage iNOS induces apoptosis following traumatic spinal cord injury. Brain Res Mol Brain Res. (2000)
  97. Xu J, et al iNOS and nitrotyrosine expression after spinal cord injury. J Neurotrauma. (2001)
  98. Hirakawa A, et al Pyrroloquinoline quinone attenuates iNOS gene expression in the injured spinal cord. Biochem Biophys Res Commun. (2009)
  99. Gong D, et al Effect of pyrroloquinoline quinone on neuropathic pain following chronic constriction injury of the sciatic nerve in rats. Eur J Pharmacol. (2012)
  100. Zhang Y, Rosenberg PA The essential nutrient pyrroloquinoline quinone may act as a neuroprotectant by suppressing peroxynitrite formation. Eur J Neurosci. (2002)
  101. Urakami T, et al Synthesis of monoesters of pyrroloquinoline quinone and imidazopyrroloquinoline, and radical scavenging activities using electron spin resonance in vitro and pharmacological activity in vivo. J Nutr Sci Vitaminol (Tokyo). (1997)
  102. Gallop PM, et al Is the antioxidant, anti-inflammatory putative new vitamin, PQQ, involved with nitric oxide in bone metabolism. Connect Tissue Res. (1993)
  103. Chapman AG Glutamate receptors in epilepsy. Prog Brain Res. (1998)
  104. Bradford HF Glutamate, GABA and epilepsy. Prog Neurobiol. (1995)
  105. Sanchez RM, et al Novel role for the NMDA receptor redox modulatory site in the pathophysiology of seizures. J Neurosci. (2000)
  106. Hoshi Y, Tamura M Dynamic changes in cerebral oxygenation in chemically induced seizures in rats: study by near-infrared spectrophotometry. Brain Res. (1993)
  107. Fujikawa DG, et al Generalized seizures deplete brain energy reserves in normoxemic newborn monkeys. Brain Res. (1988)
  108. Dannhardt G, Kohl BK The glycine site on the NMDA receptor: structure-activity relationships and possible therapeutic applications. Curr Med Chem. (1998)
  109. Kornhuber J, Weller M Psychotogenicity and N-methyl-D-aspartate receptor antagonism: implications for neuroprotective pharmacotherapy. Biol Psychiatry. (1997)
  110. Jensen FE, et al The putative essential nutrient pyrroloquinoline quinone is neuroprotective in a rodent model of hypoxic/ischemic brain injury. Neuroscience. (1994)
  111. Zhang Y, Feustel PJ, Kimelberg HK Neuroprotection by pyrroloquinoline quinone (PQQ) in reversible middle cerebral artery occlusion in the adult rat. Brain Res. (2006)
  112. Zhang L, et al The neuroprotective effect of pyrroloquinoline quinone on traumatic brain injury. J Neurotrauma. (2012)
  113. Ohwada K, et al Pyrroloquinoline Quinone (PQQ) Prevents Cognitive Deficit Caused by Oxidative Stress in Rats. J Clin Biochem Nutr. (2008)
  114. Zhang P, et al Protection of pyrroloquinoline quinone against methylmercury-induced neurotoxicity via reducing oxidative stress. Free Radic Res. (2009)
  115. Zhang P, et al In vitro protective effects of pyrroloquinoline quinone on methylmercury-induced neurotoxicity. Environ Toxicol Pharmacol. (2009)
  116. Takatsu H, et al Effect of vitamin E on learning and memory deficit in aged rats. J Nutr Sci Vitaminol (Tokyo). (2009)
  117. Nakano M, et al Effect of Pyrroloquinoline Quinone (PQQ) on mental status of Middle-Aged and Elderly Persons. Food Style. (2009)
  118. Itoh Y, et al Effect of the Antioxidant Supplement Pyrroloquinoline Quinone Disodium Salt on Cognitive Functions . Adv Exp Med Biol. (2016)
  119. Nakano M, et al Effects of Oral Supplementation with Pyrroloquinoline Quinone on Stress, Fatigue, and Sleep. Funct Foods Health Dis. (2012)
  120. Zhu BQ, et al Pyrroloquinoline quinone (PQQ) decreases myocardial infarct size and improves cardiac function in rat models of ischemia and ischemia/reperfusion. Cardiovasc Drugs Ther. (2004)
  121. Tao R, et al Pyrroloquinoline quinone preserves mitochondrial function and prevents oxidative injury in adult rat cardiac myocytes. Biochem Biophys Res Commun. (2007)
  122. Zhu BQ, et al Comparison of pyrroloquinoline quinone and/or metoprolol on myocardial infarct size and mitochondrial damage in a rat model of ischemia/reperfusion injury. J Cardiovasc Pharmacol Ther. (2006)
  123. Singh SK, et al The connection between C-reactive protein and atherosclerosis. Ann Med. (2008)
  124. Stella C, et al Susceptibility of human metabolic phenotypes to dietary modulation. J Proteome Res. (2006)
  125. Muoio DM, Koves TR Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC1 alpha: implications for metabolic disease. Appl Physiol Nutr Metab. (2007)
  126. Odkhuu E, et al Inhibition of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ). Immunol Lett. (2012)
  127. Zhao Q, et al NFATc1: functions in osteoclasts. Int J Biochem Cell Biol. (2010)
  128. Takayanagi H, et al Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. (2002)
  129. Ikeda F, et al Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J Clin Invest. (2004)
  130. Wagner EF, Eferl R Fos/AP-1 proteins in bone and the immune system. Immunol Rev. (2005)
  131. Abraham AK, et al Mechanisms of interferon-beta effects on bone homeostasis. Biochem Pharmacol. (2009)
  132. Takayanagi H, et al RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature. (2002)
  133. Takayanagi H, et al Interplay between interferon and other cytokine systems in bone metabolism. Immunol Rev. (2005)
  134. Tremblay F, et al Role of dietary proteins and amino acids in the pathogenesis of insulin resistance. Annu Rev Nutr. (2007)
  135. Omata J, et al Influence of adding pyrroloquinoline quinone to parenteral nutrition on gut-associated lymphoid tissue. JPEN J Parenter Enteral Nutr. (2011)
  136. Hogg N1, et al Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem J. (1992)
  137. Rein D, et al Epicatechin in human plasma: in vivo determination and effect of chocolate consumption on plasma oxidation status. J Nutr. (2000)
  138. Xiong XH, et al Production and radioprotective effects of pyrroloquinoline quinone. Int J Mol Sci. (2011)
  139. Tsuchida T, et al The protective effect of pyrroloquinoline quinone and its derivatives against carbon tetrachloride-induced liver injury of rats. J Gastroenterol Hepatol. (1993)
  140. Adachi O, et al New developments in oxidative fermentation. Appl Microbiol Biotechnol. (2003)
  141. Matsushita K, et al Escherichia coli is unable to produce pyrroloquinoline quinone (PQQ). Microbiology. (1997)
  142. Smidt CR, et al Does the intestinal microflora synthesize pyrroloquinoline quinone. Biofactors. (1991)
  143. Shankar BS, et al Role of glutathione in augmenting the anticancer activity of pyrroloquinoline quinone (PQQ). Redox Rep. (2010)
  144. He K, et al Antioxidant and pro-oxidant properties of pyrroloquinoline quinone (PQQ): implications for its function in biological systems. Biochem Pharmacol. (2003)
  145. Sato K, Toriyama M Effect of pyrroloquinoline quinone (PQQ) on melanogenic protein expression in murine B16 melanoma. J Dermatol Sci. (2009)
  146. Kosano H, et al Pyrroloquinoline quinone (PQQ) inhibits the expression of tyrosinase mRNA by alpha-melanocyte stimulating hormone in murine B16 melanoma cells. Life Sci. (1995)
  147. Irizarry MC, et al Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson’s disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity. J Neuropathol Exp Neurol. (1998)
  148. Wakabayashi K, et al NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson’s disease. Neurosci Lett. (1997)
  149. Spillantini MG, et al Alpha-synuclein in Lewy bodies. Nature. (1997)
  150. Sode K, et al Engineered alpha-synuclein prevents wild type and familial Parkin variant fibril formation. Biochem Biophys Res Commun. (2005)
  151. Moussa CE, et al Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine. Biochemistry. (2004)
  152. Kim TD, Paik SR, Yang CH Structural and functional implications of C-terminal regions of alpha-synuclein. Biochemistry. (2002)
  153. Zhu M, et al The flavonoid baicalein inhibits fibrillation of alpha-synuclein and disaggregates existing fibrils. J Biol Chem. (2004)
  154. Kim J, et al The inhibitory effect of pyrroloquinoline quinone on the amyloid formation and cytotoxicity of truncated alpha-synuclein. Mol Neurodegener. (2010)
  155. Liu CW, et al A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease. J Biol Chem. (2005)
  156. Andrew R, et al The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls. Neurochem Res. (1993)
  157. Hara H, Hiramatsu H, Adachi T Pyrroloquinoline quinone is a potent neuroprotective nutrient against 6-hydroxydopamine-induced neurotoxicity. Neurochem Res. (2007)
  158. Yokota T, et al Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. Biochem Biophys Res Commun. (2003)
  159. Lev N, et al Oxidative insults induce DJ-1 upregulation and redistribution: implications for neuroprotection. Neurotoxicology. (2008)
  160. Bonifati V, et al Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science. (2003)
  161. Nunome K, et al Pyrroloquinoline quinone prevents oxidative stress-induced neuronal death probably through changes in oxidative status of DJ-1. Biol Pharm Bull. (2008)
  162. Zhou W, et al The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein. J Mol Biol. (2006)
  163. Kobayashi M, et al Pyrroloquinoline quinone (PQQ) prevents fibril formation of alpha-synuclein. Biochem Biophys Res Commun. (2006)
  164. Zhang JJ, Zhang RF, Meng XK Protective effect of pyrroloquinoline quinone against Abeta-induced neurotoxicity in human neuroblastoma SH-SY5Y cells. Neurosci Lett. (2009)
  165. Watanabe A, et al Nephrotoxicity of pyrroloquinoline quinone in rats. Hiroshima J Med Sci. (1989)